News|Webcasts|October 31, 2023

Reducing Trial Cycle Times: Highlighting the Importance of Efficient Forecasting and Team Building

Author(s)IQVIA

Webinar Date/Time: Thursday, November 30th, 2023 at 3pm EST | 12pm PST | 8pm GMT | 9pm CET

The pharma industry is facing an ever-increasing pressure to reduce clinical trial cycle times and complete study start-up with the utmost speed and efficiency. The IQVIA team of clinical FSP specialists will walk you through how to traverse the volatility in starting up a trial and forecasting what is required to ensure a speedy delivery and set-up.

Register Free:
https://www.appliedclinicaltrialsonline.com/act/team-building

Event overview
The pharma industry is facing an ever-increasing pressure to reduce clinical trial cycle times and complete studies with the utmost speed and efficiency. In order to support the reduction of white space within start-up it is essential that consideration is given to planning, resourcing, technology and processes.

In this latest webinar from IQVIA FSP our team of clinical FSP specialists will walk you through how to traverse the volatility in starting up a trial and forecasting what is required to ensure a speedy delivery and set-up. We’ll highlight how the need for in-depth resource forecasting including task navigation and building the right team structure with the right skills and knowledge are imperative in study start-up.

We’ll also outline where applying co-design processes, technology, and being able to measure success add value to your outsourcing partnerships.

Three key take-aways

  • Providing realistic planning, consistency, and measurements by utilizing the benefits FSP of a partnership
  • When and where to add “co-design” and technology to enhance study start-up
  • Learn the importance of how to structure study start-up in an outsourced partnership that leads to great efficiency, speed, and trial development.


Speakers:

Kelly Powell
VP Clinical Operations – FSP Outsourcing
Global Alliance Lead – IQVIA

Kelly holds a B.Sc (Hons) in Neuroscience from the University of Sussex and a D.Phil in cell cycle research from the Medical Research Council (UK). She has been part of the clinical FSP team at IQVIA since 2016. Kelly currently manages a global FSP partnership. She led the initial transition to IQVIA from an incumbent CRO in early 2021 and again into a sole provider relationship in 2022. Prior to that, Kelly was the Regional Head of FSP for the Asia Pacific Region. She has 20 years of experience in the industry.

Prior to joining IQVIA, Kelly held roles in Alliance, Project, and Clinical Operations management. She initially started her career as a CRA in the UK and relocated to Singapore in 2009 returning to the UK in 2021.


Lorenzo Parma
Director Solution Engineering
IQVIA

Lorenzo is a strong clinical research professional with a PhD in Biology from Milan University and a Master of Business Administration from Warwick Business School. He has more than 15 years of experience in the Life Science Industry with roles in Clinical Ops, Business Development, Data and Clin Tech. Lorenzo strategically supports clinical tech solutions for Large Pharma companies and is actively involved in different clinical process and technology improvement and optimization workstreams (i.e. site payment, site interaction, start up, contract negotiation, budgeting, enrollment optimization). Lorenzo is Italian but moved to Basel, Switzerland, 4 years ago with the family.

Register Free:
https://www.appliedclinicaltrialsonline.com/act/team-building


Related to this article

© photon_photo - © photon_photo - stock.adobe.com
Standardized measurement across five oncology centers found that clinical research coordinators rated eSource-enabled workflows positively (Overall Mean Satisfaction 5.79 of 7), with reduced manual entry and electronic data transfer earning strong marks, while perceived reduction in sponsor and monitor queries lagged as the one domain below threshold.
Where the Industry Is Headed as Clinical, Operational, and Real-World Data Connect
In this video interview, Rajneesh Patil, global head of AI, digital, and innovation in clinical development at Syneos Health, describes the industry’s trajectory toward a unified intelligence orchestration environment—and explains why the future isn’t one model that knows everything, but a trusted system that brings the right evidence to the right human decision.
What Expanding AI Ecosystems Mean for Sponsor Complexity and Oversight
In this video interview, Rajneesh Patil, global head of AI, digital, and innovation in clinical development at Syneos Health, argues that CROs must act as orchestrators rather than aggregators—and that the real test of any AI ecosystem is whether it reduces sponsor coordination burden or just hands it back to them.
The Human Side of Clinical Trials: Why Fuzzy Mental Models Undermine Clinical Trial Execution
In Episode 3 of The Human Side of Clinical Trials, hosts Brian S. McGowan, PhD, FACEHP, chief learning officer and co-founder of ArcheMedX, Inc., and Kelly Ritch, chief operating officer of ArcheMedX, Inc., speak with Jason Riis, PhD, CEO and chief behavioral scientist at Behavioralize, about why a well-written protocol doesn’t always translate into consistent execution, and how designing for the way people actually think and learn can reduce site burden and the need for costly unlearning.
© putilov_denis - © putilov_denis - stock.adobe.com
Real-time clinical trials require standardized digital data capture at the point of care through scaled eSource-EDC-EHR integration, but progress stalls because competing standards lack regulatory enforcement and one-off system integrations cannot scale beyond single studies without industry-wide alignment and legal clarity on data ownership.